血管紧张素转换酶
发病机制
肾素-血管紧张素系统
医学
血管紧张素转换酶抑制剂
酶
肽基二肽酶A
糖尿病
胰腺
血管紧张素转化酶2
内科学
血管紧张素II
受体
药理学
血压
内分泌学
疾病
生物
生物化学
2019年冠状病毒病(COVID-19)
传染病(医学专业)
作者
Vatsala Khurana,Binita Goswami
标识
DOI:10.1016/j.cca.2021.10.029
摘要
Angiotensin converting enzyme (ACE) was isolated as a 'hypertensinconverting enzyme'. There have been considerable advances in understanding the metabolic role of ACE in the body. This review attempts to highlight the role of ACE enzyme in the physiological and pathological processes occurring in the organs in which it is localized.The literature was searched from the websites of the National Library of Medicine (http://www.ncbi.nlm.nih.gov/) and Pub Med Central, the U.S. National Library of Medicine's digital archive of life sciences journal literature.The involvement of ACE in regulation of blood pressure forms its central action but it has a role to play in a variety of physiological processes occurring in the organs in which it is localized like the lungs, macrophages, brain, pancreas, liver etc. It has also been implicated in the pathogenesis of a number of diseases including COVID-19.More studies need to be carried out in order to validate the use of ACE levels in the diagnosis and monitoring of the diseases associated, and facilitate the use of ACE inhibitors and Angiotensin Receptor Blockers in the management of the same, so this wonder molecule can be utilized to its full potential.
科研通智能强力驱动
Strongly Powered by AbleSci AI